Evidence map›Paper›PMID 30064122›Full record

SynthesisAging2018

Human methionine synthase A2756G polymorphism increases susceptibility to prostate cancer.

Hong-Bao Shao, Kewei Ren, Sheng-Lin Gao, Jian-Gang Zou, Yuan-Yuan Mi, Li-Feng Zhang, Li Zuo, Atsushi Okada, Takahiro Yasui

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 9 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 9 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. TheFrontiers in immunology · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Association of apolipoprotein B XbaI (rs693) polymorphism and gallstone disease risk based on a comprehensive analysis.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Hong-Bao Shao *Department of Urology, Third Affiliated Hospital of Nantong University, Wuxi 214041, China.
Kewei Ren *Department of Orthopedics, the Affiliated Jiangyin Hospital of Southeast University Medical School, Jiangyin 214400, China.
Sheng-Lin Gao *Department of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Jian-Gang ZouDepartment of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Yuan-Yuan MiDepartment of Urology, Third Affiliated Hospital of Nantong University, Wuxi 214041, China.
Li-Feng ZhangDepartment of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Li ZuoDepartment of Urology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Atsushi OkadaDepartment of Nephrourology, Nagoya City University Graduate School of Medical Sciences, Aichi 4678601, Japan.
Takahiro YasuiDepartment of Nephrourology, Nagoya City University Graduate School of Medical Sciences, Aichi 4678601, Japan.
Changzhou No.2 People's Hospital · CNNagoya City University · JPWuxi Third People's Hospital · CNSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsPrevious results on the association between MTR gene A2756G polymorphism and PCa risk are inconclusive.

methodsWe used odds ratios (ORs) with corresponding 95% confidence intervals (95% CIs) to evaluate the correlation between MTR A2756G polymorphism and risk of PCa in meta-analysis. Serum expression of MTR was detected by ELISA and

resultsOur study included 2,921 PCa patients and 3,095 control subjects. The results indicated that the MTR A2756G polymorphism is linked with an increased risk of PCa using three genetic models (G-allele vs. A-allele: OR = 1.16, 95%CI = 1.04 - 1.30; GA vs. AA: OR = 1.17, 95%CI = 1.02 - 1.33; GG+GA vs. AA: OR = 1.18, 95%CI = 1.04 - 1.34). Stratified analysis produced similar results. A significant association was also indicated in advanced PCa from the meta-analysis. Finally, our experiments showed evidence that serum MTR levels in PCa patients with AA genotypes were statistically higher than in those with GG/GA genotypes.

conclusionsOur present study suggests that the MTR A2756G polymorphism may contribute to the risk of developing PCa, particularly in Asian and hospital-based studies. Moreover, serum MTR might be utilized in diagnosis of PCa.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single Nucleotide5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseAgedAged, 80 and overComputer SimulationGene Expression Regulation, EnzymologicGenotypeHumansMaleMiddle AgedModels, BiologicalProstatic Neoplasms5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseMTR protein, humanELISAgenetic variationmethionine synthasepolymorphismprostate cancer

Identifiers

PMID30064122
PMCPMC6075445
OpenAlexW2887714266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.